News & Latest Announcements
Kid Gloves vs. Core Change: Is Your Trial Accommodating or Truly Re-engineered?
Many clinical trials today treat patient burden with kid gloves—offering comforts and courtesies to soften the blow of a fundamentally flawed process. But what if we…
Read article
Patient-Centricity in Autoimmune CAR-T
CAR-T therapies have already redefined treatment options in hematologic cancers, and today the same innovation is beginning to transform the way we approach autoimmune diseases such…
Read article
Beyond Friendly: What True Patient Centric Trials Look Like
Nearly 80% of clinical trials fail to enroll on time. Behind this number are delayed treatments and missed opportunities for patients. Too often, the terms friendly…
Read article
Your Regulatory Dream Team
Navigating the regulatory landscape is one of the most crucial, and often most complex, steps in bringing innovative allogeneic CAR-T therapies to market. For biotech companies…
Read article
Speed Without Compromise: CRO Flexibility
In the rapidly evolving landscape of cell therapy, particularly with the rise of allogeneic (“off-the-shelf”) CAR-T treatments, agility and expertise are no longer optional—they are essential.…
Read article
The High Stakes of Picking the Wrong CRO in Allogeneic Development
Choosing an adequate CRO for an allogeneic cell therapy trial is a critical decision that can determine the success or failure of a program. Allogeneic cell…
Read article
Why Agility is the New Gold Standard in Allogeneic CAR-T Trials
The field of oncology is undergoing a dramatic transformation, driven by the rise of cell therapies. For years, the gold standard was autologous CAR-T therapy, a…
Read article
Advancing Phase I Clinical Research: Our Expertise in PK/PD Studies
Merging Science, Compliance, and Decades of Biosimilar Expertise Phase I clinical research is the foundation of every successful drug development program—determining a compound’s safety, pharmacokinetics (PK),…
Read article
Accelsiors at Swiss Biotech Days 2025: Bridging Innovation, Cultures, and Chocolate
On 5–6 May, Basel buzzed with biotech brilliance as Swiss Biotech Days 2025 united over 3,000 innovators and investors from across theglobe. As a Swiss-headquartered CRO…
Read article